Our new partnership with Eli Lilly and Company brings together Magnet's TrueGlue? discovery platform with Lilly's expertise in developing small molecule therapeutics to enable breakthrough medicines for cancers with significant unmet medical need. ???Visit our website to learn more about how we’re harnessing the untapped potential of molecular glues:??https://magnetbio.com #MolecularGlues #Biotech #TrueGlue
Magnet Biomedicine
生物技术研究
Boston，Massachusetts 2,355 位关注者
Revolutionizing Human Medicine with Molecular Glues
关于我们
Magnet Biomedicine is a biotechnology company advancing molecular glue discovery with rational selection and design. We are reimagining what is achievable with molecular glues by looking beyond known protein–protein interactions and analyzing the broad protein landscape to pair target proteins with rationally selected presenter proteins to drive therapeutic effects. Our TrueGlue? discovery platform applies cutting-edge advancements in human biology and proteomics to identify fit-for-purpose glues that offer category-leading benefits and maximize therapeutic impact.
- 网站
-
https://www.magnetbio.com
Magnet Biomedicine的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
地点
-
主要
获取路线
321 Harrison Ave
US，Massachusetts，Boston，02118
Magnet Biomedicine员工
动态
-
???NEWS: We are proud to announce a collaboration and license agreement with Eli Lilly and Company to discover, develop, and commercialize molecular glue therapeutics?to enable novel therapeutic mechanisms of action. View our latest press release to learn more:?https://lnkd.in/eAKY2X5q Visit our website to explore our approach: https://magnetbio.com/ #MolecularGlues #Biotech #TrueGlue
-
-
Today, we celebrate the incredible contributions of women and girls in the scientific community and acknowledge the importance of diversity and inclusion in driving innovation. At Magnet Biomedicine, we are proud to support and empower women in STEM fields, fostering an environment where their talents and ideas can thrive. Let's continue to inspire the next generation of female scientists, engineers, and innovators!
-
-
We are excited to share,?Matthew Hayward, Vice President of Drug Discovery will be speaking at the upcoming 4th Annual Induced Proximity – Based Drug Discovery Summit, happening July 23rd – 25th ! To explore his session, download the 2024 event guide here - https://ter.li/tup33q
-
We are excited to share that Matthew Hayward, Vice President of Drug Discovery, will be attending and speaking at the upcoming ACS National Medicinal Chemistry Symposium next week! Matthew will be discussing and sharing our innovative molecular glue plateform. See you next week!
The 38th #NMCS meeting will include a session on advances in protein proximity, induction, and degradation, and features presentations from Michelle Arkin, Matthew Hayward, Kat Kayser-Bricker, Lingling Shen, Magnus Walter and Ning Zheng Don't forget to register before the early bird deadline! https://lnkd.in/exnKmk6h
-